Breast Cancer Cells May Go Into ‘Sleeper Mode’ After Treatment

Highlights:

Hormonal treatment of breast cancer destroys cancer cells but induces some tumor cells to enter a “sleeping or dormant” state, that could awaken long after treatment is complete
About 30% of breast cancer patients who receive hormone treatments have a recurrence of their cancer up to 20 years later, and this returning cancer is more aggressive and much more difficult to treat
Future research needs to focus on ways to tackle these “dormant cells”, preventing cancer recurrence and potentially saving the lives of innumerable women with breast cancer

Hormonal treatment of breast cancer destroys cancer cells but induces some tumor cells to enter into a sleeping or dormant state, that could awaken long after treatment is complete, resulting in cancer recurrence, according to research undertaken by scientists at Imperial College London.

Listen to this article

0:00/0:00

Modified Drug Combo Reduces Breast Cancer Recurrence Risk
New study suggests using albumin-based drug nab-paclitaxel prior to surgery to improve chances for a complete pathologic response during surgery in patients with triple negative breast cancer.

‘Approximately 30% of breast cancer patients who received hormone treatments have a recurrence of cancer. Hormonal treatment may destroy some cancer cells but induce other cells to enter a sleeping or dormant state. Further research is needed to tackle these ‘sleeper cells,’ preventing cancer recurrence and potentially saving the lives of innumerable women with breast cancer.’
Read More..

Tweet it Now

The findings of the study appear in the journal Nature Communications.

Do Hormonal Treatments Induce Cancer Cells to Enter a Dormant State?

An important component of breast cancer treatment is hormonal treatment. This includes targeted hormone therapy such as aromatase inhibitors or tamoxifen, that block estrogen receptor that are believed to fuel tumor growth.
For reasons that remain unclear, scientists believe that the hormonal treatment triggers tumor cells to enter an "inactive dormant" state only to become reactivated even several years after initial treatment causing cancer recurrence that is often associated with a poorer prognosis

The research team undertook the study to gain more insight into this phenomenon and find possible answers on how and why some cancer cells entered a dormant state and became active later.

Dr Luca Magnani, from Imperial's Department of Surgery and Cancer and lead author of this study, said: "For a long time scientists have debated whether hormone therapies - which are a very effective treatment and save millions of lives - work by killing breast cancer cells or whether the drugs flip them into a dormant 'sleeper' state. If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back, either by holding the cells in permanent sleep mode, or be waking them up and killing them."

Unlocking Effects of Hormone Therapy on Breast Cancer Cells

The team looked at 50,000 single breast cancer cells in the lab
They found that exposing the tumor cells to hormones rendered at least some of these cells to enter into an inactive dormant state
Interestingly, these dormant or sleeper cells appear to be an intermediate stage before cancer becomes resistant to treatment
These sleeper cells were also more likely to travel around the body and spread to distant sites and may wake up in other sites resulting in secondary cancers

The findings of the study suggest that hormonal treatment does induce some cancer cells to become inactive only to awaken later leading to cancer recurrence that has spread to distant sites and also more difficult to treat.

Obesity Increases the Risk of Recurrence of Breast Cancer
Breast cancer is one of the commonest types of cancer seen in women. Hormone receptor-positive breast cancer accounts for two-thirds of all incidents of breast cancer worldwide.

In fact, previous research by the same team had analyzed how breast cancer cells become resistant to hormone treatment, and found that cancer cells make their own 'fuel' that prevents them from being starved of energy to grow by the cancer drugs. The findings of the current study could be another piece in the puzzle seeking answers to hormonal effects on breast cancer cells.

The exact mechanism by which the breast cancer cells switch off and enter a dormant mode and switch back on to an active mode is not clear, but the study team feel that unlocking the secrets of these dormant cells might help in preventing cancer recurrence, either by keeping the cells permanently in the sleep mode, or activating them and killing them.

Scope of the Study

Further research can determine if prolonging duration of hormone treatment for breast cancer could prevent sleeper cancer cells from waking up
Future research can identify how "dormant" cells are created and explore methods to tackle these "dormant" cells and preventing cancer recurrence

In summary, hormonal treatment of breast cancer may induce some tumor cells to go into a "dormant sleeper" state, which may cause recurrence of breast cancer even after treatment, at a later date. Effective ways to tackle these dormant cells need to be found in order to save the lives of several women diagnosed with breast cancer.

Reference :

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy - (https://doi.org/10.1038/s41467-019-11721-9)

Source: Medindia

Font : A-A+

Breast Cancer Risk Assessment Calculator
Breast Cancer Risk Assessment Calculator predicts the risk for breast cancer. Find list of breast cancer facts and more information on signs and symptoms of breast cancer and mammography.

Cite this Article

<< Chikungunya Virus Causes Chronic Joint Pain: Here’s How

New Drug Combination may Extend the Lives of Lung Transplant... >>

Web-based Calculator to Predict If Breast Cancer Will Recur
Should estrogen hormone therapy for five years following standard treatment for breast cancer be continued? Clinicians can now use the newly developed calculator to help find if you are at a high risk of breast cancer recurring.